Baxter International stock rises on 24.5 percent YTD gain
Published on 09/15/2026 at 16:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Baxter International Inc. (ISIN US0673431090) closed at USD 23.80 on the NYSE on September 11, 2026, leaving Baxter International stock 24.5 percent higher since the start of 2026. The latest public summary on ad hoc news tied that move to the last completed session and framed the stock's recent strength around the same close.
Q2 revenue beats peers
For the most recent reported quarter, Finance Yahoo said Baxter reported revenue of USD 2.96 billion, up 5.3 percent year on year and 6 percent above analyst expectations. That is the number investors are still digesting.
The same source said the quarter was strong enough for Baxter to beat full-year EPS guidance estimates, while the shares were still trading at USD 23.91 in that snapshot. For a stock that already had a 24.5 percent year-to-date gain by September 11, 2026, the gap between operating progress and the market's muted day-to-day reaction stands out.
What matters next
One fresh date still anchors the story: September 11, 2026. On that day, Baxter's NYSE close of USD 23.80 sat on a year-to-date base that is materially higher than at the start of the year, while the Q2 revenue figure of USD 2.96 billion and the 5.3 percent growth rate show why the stock has support under it.
Stock and valuation
Baxter International stock traded at USD 23.80 on the NYSE on September 11, 2026. The same session was marked by a 24.5 percent year-to-date gain, a price level that keeps the stock well above its early-2026 starting point.
Baxter International stock facts
- Company: Baxter International Inc.
- ISIN: US0673431090
- Ticker: BAX
- Trading venue: NYSE
- Price (as of September 11, 2026): USD 23.80
- Sector / Industry: Healthcare / Medical Devices
- Index membership: S&P 500
